Results CD38 gene expression is associated with key immune suppressive markers in SCLC To explore the relationship between the expression of CD38 and potential immunosuppression in SCLC, we evaluated ...

Elevated NLR may no longer predict poor survival outcomes in patients with small cell lung cancer (SCLC) receiving immunotherapy, according to new research.

Object Details Created by Student Nonviolent Coordinating Committee, American, 1960 - 1970s Owned by Jan Bailey, American, 1942 - 2010 Description Black and white flyer with a large image of two hands ...

Los Angeles honored Juneteenth 2025 with 3 days of celebrations, including music, dialogue, food, and empowerment across the city.

Serplulimab was granted orphan drug designations by the FDA and the EC for the treatment of SCLC, and its bridging head-to-head trial in the United States to compare serplulimab to standard of ...

Intas and its subsidiary Accord Healthcare lead commercialisation in Europe and India. In December 2022, serplulimab received orphan drug designation from the EC for the treatment of SCLC, this ...

Small cell lung cancer is aggressive and spreads quickly. There are many options for treatment, depending on the type and stage of SCLC.

Say what you want about Juneteenth, either it is just so much ado about getting news after-the-fact, or another opportunity to raise national – no, ...